News

INVITATION TO THE ANNUAL MEETING

Published

Uncategorized

The shareholders of AUXESIS PHARMA HOLDING AB (publ) with organization number 559195-6486 are hereby invited to the annual general meeting on
June 16, 2023 at 15.00 at Ramberg Law at Jakobsbergsgatan 13 in Stockholm Sweden.

Pitch update

New updated Pitch, Memorandum and Scenario Valuation 2023 for download.

Auxesis Pharma Pitch 2023

Auxesis Pharma Memorandum 2023

Auxesis Pharma Scenario Valuation 2023

Shareholder Information

Document regarding registration of sharholders deposit information is available for download in the Investor Hub.

Scenario valuation 2023

Valuation AUXESIS 03/2023

Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is now available.

Investor Forum

Investor Invitation

We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden.

On site you will have the opportunity to meet the founder and CEO Roar Adelsten, the research supervisor Professor Moustapha Hassan and key people in the company’s management team.

AUXESIS PHARMA HOLDING AB (publ) Investor Forum will cover the history of our product development, how it has changed over time and where it is headed in the future. We will also discuss the latest research in this field. Welcome!

Euroclear

News Euroclear Sweden

AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client to Euroclear Sweden, Auxesis Pharma becomes a part of the hub in the Swedish financial market. With advantages such as reduced administration and easier to raise capital, the company also becomes prepared for a listing on the stock exchange in the near future. A register of shareholders is a list that shows who owns shares in the company. According to the Swedish Companies Act (ABL), all limited companies must have a register of shareholders. 

Memorandum

Update

There is exciting news in Auxesis Pharma. Trademarks, new areas of application, clinical studies and trials,

production facilities, to name a few. Complete pdf update for download available. Share subscription is still open. 

Share Issue Offering

Do you want to join the journey?

AUXESIS PHARMA HOLDING AB (publ) is increasing its stock with maximum 600.000 shares at a price of SEK 59 sek/share.

Click below and you will find detailed information.

Memorandum  

Auxesis Pharma Holding AB (publ) 

Scenario Valuation 

Auxesis Pharma Holding AB (publ)

Public Limited Company

AUXESIS PHARMA HOLDING AB (publ) is now registered with the Swedish Companies Registration Office as a Public Limited Company (PLC) with a share capital of SEK 500,000. A PLC has the right to distribute shares, subscription rights and other securities to the public. 

Scenario valuation

Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is now available.